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Abstract
Background: Multidrug resistance (MDR) phenotype of malignant cells is the major problem in
the chemotherapy of neoplasia. The treatment of leukemia with retinoids is aimed on the induction
of leukemic cells differentiation. However the interconnections between retinoid regulated
differentiation of leukemic cells and regulation of MDR remains unclear.
Methods: Four lines of cultured leukemic cells of diverse types of differentiation were infected
with RARα  gene and stable transfectants were isolated. We investigated the differentiation of these
cells as well as the expression of RARα  and MDR1 genes and P-glycoprotein (Pgp, MDR protein)
functional activity in these cells.
Results: All RARα  transfected sublines demonstrated the increase in the quantity of RARα  mRNA.
All these sublines became more differentiated. Intrinsic activity of MDR1  gene (but not Pgp
functional activity) was increased in one of the transfectants. All-trans-retinoic acid (ATRA) induced
Pgp activity in two of three infectants to a larger extent than in parental cells.
Conclusion: The data show that RARα  regulates MDR1/ Pgp activity in human leukemic cells, in
the first place, Pgp activity induced by ATRA. These results show that RARα  overexpression in
leukemic cells could result in MDR.
Background
Multidrug resistance (MDR) phenotype of malignant cells
is the major problem in the chemotherapy of neoplasia. P-
glycoprotein (Pgp) activity is recognised to be one of the
major mechanisms responsible for MDR. Pgp transports
many structurally diverse compounds across the cell
membrane and confers the MDR phenotype in tumor
cells [1]. A number of signaling pathways participate in
the regulation of MDR1 gene expression and the activity
of its product, Pgp [2]. Some of these signaling pathways
could participate in coordinated regulation of MDR1/Pgp
activity, cell proliferation and cell differentiation. It was
shown that retinoic acid (RA) can modulate MDR1 gene
expression [3-5]. Retinoids are known to be involved into
the regulation of the cell growth, differentiation and
apoptosis. In the last decade retinoids became implicated
into the treatment of leukemia and some solid tumors [6].
This approach changed the focus of the haematological
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diseases treatment from the cytotoxicity of the anti-cancer
drugs to the reversal of arrested maturation of leukemic
cells. Retinoids act via two families of receptors (RARs –
RARα , RARβ , RARγ ) and RXRs (RXRα , RXRβ , RXRγ ). There
is the evidence that RARα  is the crucial receptor mediating
the biological effects during retinoid signaling in some
cells [7]. Cell differentiation caused by the stable overex-
pression of receptor RARα  was shown to result in consti-
tutive over expression of MDR1 gene in some cultured
cells of solid tumors [4]. However the interconnections
between RA/RARα  regulated differentiation of leukemic
cells and regulation of MDR1/Pgp activity remains
unclear. In some leukemic cells RA did not influence
MDR1 and/or Pgp activity, while in the others it either
augmented or reduced MDR1/Pgp expression [5,8]. The
aim of this study is to investigate if effects of all-trans-retin-
oic acid (ATRA) on MDR1/Pgp activity in leukemic cells
are connected with RARα  expression and with the leuke-
mic cell differentiation. We isolated sublines of cultured
leukemic cells characterized by the stable RARα  overex-
pression and investigated the constitutive and ATRA
induced MDR1/Pgp activity in these cells. Our data show
that various RARα  transformed leukemic cell lines
acquired more differentiated phenotype. Constitutive
level of MDR1 gene expression increased in one of RARα
overexpressing cell sublines. RARα  overexpression did not
influence Pgp functional activity while Pgp activity
induced by ATRA was elevated in all infectants studied.
This shows that the main effect of RARα  in the cells stud-
ied is its influence on the induced functional activity of
Pgp.
Methods
Cell lines and culture
Lines of cultured leukemic cells used in the study: H9 cells
(acute human T-cell leukemia) [9], KG-1 cell line (cells of
acute myelogenous leukemia) [10], K562 cell line (cells
obtained from the patient in blast crisis of chronic mye-
loid leukemia) [11], NB4 (acute promyelocytic leukemia)
[12].
Cells were grown in RPMI-1640 medium supplemented
with 10% fetal calf serum (Gibco, USA), 2 mM L-
glutamine, 50 µg/ml gentamycin at 37°C in a fully
humidified atmosphere of 95% air and 5% CO2. All the
derived cell lines described in this paper were obtained by
retroviral infection and selection with the appropriate
antibiotic. ATRA (all-trans-retinoic acid, Sigma, USA) was
added to the culture medium at seeding or 24 hours after
seeding (see Legends to Figures).
Expression vector and retrovilal infection
The PA317/LRARSN retroviral vector-producing cell line
was used. All the procedure was described earlier [4]. In
brief, the vector used contains a cDNA fragment harbour-
ing the complete coding sequence of the RARα  gene
driven by the Moloney murine leukemia virus long-termi-
nal repeat as well as the SV40 early promoter-driving neo-
mycin phosphotransferase gene (neo) as a selectable
marker [13]. The cells (4 × 105 per 25-cm2 flask) were
seeded 24 h before infection. Conditioned medium from
a retrovirus-producing cell line was filtered through a
0.45-µm membrane (Millipore, USA), diluted 1:1 with
medium, containing 1% serum and 8 µg /ml Polybrene
and added to the cells for 24 h at 37°C, 5% CO2. Further
selection were carried out by culturing cells in medium
supplemented with 400 µg/ml G418 (Gibco, USA) for at
least 21 days. The medium was changed twice a week. The
pool of G418-resistant cells was resuspended in culture
medium and progressively expanded.
Assay of cell growth, apoptosis and differentiation
Cells were seeded into 24-well plates (1 × 104 cell per
well) and the cell number was counted at days 1, 3, 5 and
8 after seeding. The apoptosis in the populations of the
parental and RARα  infected cell lines was performed using
the standard procedure [14]. Cells were collected 24 h
after seeding, washed with PBS, and fixed in 70% ethanol
overnight at 4°C. Fixed cells were suspended in citric
buffer and stained with propidium iodide (5 mcg/ml) in
PBS for 1 hour at 4°C. DNA content was subsequently
measured by FACScan (Becton Dickinson, USA).
The immunophenotype of the cells was evaluated as pre-
viously described [15]. Surface expression of the following
antigens was determined: CD3, CD5, CD7, CD8, CD11b,
CD13, CD15, CD33, CD34, HAE3 and HAE9. In brief,
cells were incubated with phycoerythrin-labelled mono-
clonal mouse antibodies for 20 min at 4°C (Becton, Dick-
inson), washed with RPMI 1640 medium and analyzed
with a flow cytometer (Becton Dickinson).
Analysis of rhodamine 123 (Rh123) efflux by the cells
The technique used in the study was described in [16].
Cells were loaded with 5 µg/ml Rh123 (Sigma) for 10 min
at 37°C, washed twice with cold PBS, pH 7.2, and incu-
bated for 30 min in dye-free medium at 37°C. After the
completion of incubation, cell were washed twice with
cold PBS. Cell fluorescence was measured on a flow
cytometer FACScan (Becton Dickinson, USA). Each meas-
urement counted 5000 events. Non-viable cells were
gated out of the analysis on the basis of side scatter.
RNA isolation and reverse transcriptase polymerase chain 
reaction (RT-PCR) analysis of RARα  and MDR1 genes 
expression
The cells were dissolved in TRI reagent (Sigma, USA).
Total RNA was isolated as described in the manufacturer's
manual. For analysis, aliquots of isolated RNA were dena-
tured with formamide and subjected to electrophoresis inCancer Cell International 2005, 5:15 http://www.cancerci.com/content/5/1/15
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1.8% agarose gels. The samples with clearly visualized 18S
and 28S RNA bands were used for further procedures.
First-strand cDNA was synthesized using reverse tran-
scriptase M-MuLV (MBI Fermentas, Russia) with 4 µg RNA
as a template, 2.5 ng random hexamers, 0.25 mM of each
deoxynucleotide triphosphate (SibEnzyme, Russia), dithi-
othreitol, 4 Units of RNAase inhibitor (MBI Fermentas,
Russia) and 100 Units of M-MuLV RT. The reaction was
performed at 42°C for 50 min, and 1/60 volume of reac-
tion mixture was used for amplification. PCR was done in
a total volume of 25 µl using the thermocycler "Tercyc"
(DNA-technology, Russia). The PCR mixture consisted of
(NH4)2SO4-containing PCR buffer ("MBI Fermentas"),
0.160 mM dNTPs mix ("MBI Fermentas"), 2 mM MgCl2,
20 pmoles of each specific primer and 0.8 Unit of Taq-
polymerase ("MBI Fermentas"). PCR was done as follows:
94°C for 2 seconds, Tm (different for each gene) for 10
seconds, 72°C for 5 seconds. Semi-quantitative PCR anal-
ysis of RARa and MDR1 genes expression were performed
using oligomers amplifying a 333 bp and 167 bp prod-
ucts, respectively. Specific gene primers used for RT-PCR
are given in Table 1. The amounts of template cDNAs were
normalized by PCR amplification of β 2-microglobulin
cDNA (internal control). The optimal numbers of PCR
cycles were 24 for the b2-microglobulin, 26 for RARα -spe-
cific product, 33 for MDR1 (for all cells lines except KG1
and KG1/RAR, for these cells the numbers of PCR cycles
MDR1-specific product were 26). These numbers of cycles
yielded clearly detectable PCR products within an expo-
nential range. PCR products were amplified in separate
tubes, resolved by electrophoresis in 2% agarose gel,
stained with ethidium bromide and visualized in UV
light.
Results
Influence of RARα  gene overexpression on cell 
differentiation, proliferation and spontaneous apoptosis
RARα   gene was introduced into the cultured leukemic
cells of diverse types of differentiation as described in
Methods. The sublines of H9, KG-1, K562 and NB4 cells
characterized by the capability to grow in the medium
supplemented with G418 were isolated (H9/RAR, KG-1/
RAR, K562/RAR and NB4/RAR). Semi-quantitative RT-
PCR revealed more pronounced expression of RARα
mRNA in all transfected cell lines in comparison with the
wild type cells (Fig. 1). ATRA (5 µM applied for 48 h)
increased RARα  mRNA in some RARα  transformed cells
(H9/RAR, KG-1/RAR, K562/RAR) to a greater extent than
in parental cells (Fig. 1).
The investigation of the differentiation status of these cells
shows that all RARα  transfected sublines differ from the
parental cell populations (Fig. 2). RARα  transfected H9
culture contains more cell variants expressing CD5 and
CD8 antigens than parental cell line (Fig. 2A). Thus the
number of cells with antigens of later lymphoid differen-
tiation markers increased in RARα   overexpressing H9
cells. There is phenotypic evidence of granulocytic differ-
entiation in KG-1/RAR cell subline as indicated by a
reduction in CD13 expression and the increase in the
expression of CD11b antigen in comparison with parental
cells (Fig. 2B). In KG-1/RAR cell population the portion of
CD34 cells decreased and the portion of CD33 cells
increased (Fig. 2B). This also testifies to increased differ-
entiation of these RARα   overexpressing cells. In K562/
RAR population the number of the cells of erythroid dif-
ferentiation (expressing HAE9 and HAE3 antigens) is
larger than in K562 population (Fig. 2C). Hemoglobin
synthesis is increased in K562/RAR culture more than 5-
fold in comparison with parental cells (not shown). In
Table 1: Specific gene primers used for RT-PCR
Gene Product 
size
Primer Sequence
RARα 333 bp F 5'-GTCTTTGCCTTCGCCAACCAG-3'
R 5'-GCCCTCTGAGTTCTCCAACA-3'
MDR1 127 bp F 5'-CCCATCATTGCAATAGCAGG-3'
R 5'-GTTCAAACTTCTGCTCCTGA-3'
β 2m 114 bp F 5'-ACCCCCACTGAAAAAGATGA-3'
R 5'-ATCTTCAAACCTCCATGATG-3'
Expression of RARα  mRNA in parental and RARα  transfected  cell lines. RT PCR Figure 1
Expression of RARα  mRNA in parental and RARα  
transfected cell lines. RT PCRM. k- – water. ATRA (5 
µM) was added to cell cultures 24 h after seeding for 48 h. 
Then the cells were collected and processed as specified in 
"Methods" (RNA isolation and reverse transcriptase 
polymerase chain reaction (RT-PCR) analysis of RARα  gene 
expression). This figure is representative of 2 separate 
experiments.Cancer Cell International 2005, 5:15 http://www.cancerci.com/content/5/1/15
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NB4/RAR population the number of the cells of myeloge-
nous differentiation (expressing CD11b and CD15 anti-
gens) is larger than in NB4 population (Fig. 2D).
The percentage of cells undergoing spontaneous apopto-
sis increased 2-3-fold in all RARα  transfected cell popula-
tions (Fig. 3). This could be connected with more
differentiated phenotype of RARα   transformed cells. It
seems that in the population of H9/RAR cells the
increased number of apoptotic cells could be at least in
part connected with increased expression of CD95 (Fas/
APO1): in this RARα  transformed subline CD95 increased
almost 10-fold in comparison with parental cell popula-
tion (from 2,6% in H9 to 21,4% in H9/RAR culture).
However in KG-1 and K562 cell populations the number
of CD95 expressing cell did not increase after RARα  trans-
formation.
As Fig. 4 shows, RARα  transfected KG-1, K562 and NB4
cells proliferated more slowly than parental cells. How-
ever H9/RAR cells did not demonstrate slower prolifera-
tion rate. Thus, more differentiated status of the RARα
transformed cell populations was not necessary connected
with the decrease in the proliferation rates. All RARα
transformed cells seem to be more sensitive than wild type
cells to inhibitory action of ATRA on cell proliferation
(Fig. 5).
Comparison of antigen expression by the parental and RARα   infected cell lines Figure 2
Comparison of antigen expression by the parental 
and RARα  infected cell lines. Cells were incubated for 30 
min at 4°C in the presence of an appropriate monoclonal 
antibody. After three washes with PBS, cells were incubated 
for 30 min at 4°C with goat antimouse IgG labeled with phy-
coerythrin and then analyzed in flow cytometer (Becton 
Dickinson).
Spontaneous apoptosis in the populations of the parental and  RARα  infected cell lines Figure 3
Spontaneous apoptosis in the populations of the 
parental and RARα  infected cell lines. Propidium iodide 
flow cytometry detection of dead cells was performed using 
the standard procedure. Cells were collected 24 h after 
seeding, washed with PBS, and fixed in 70% ethanol overnight 
at 4°C. Fixed cells were suspended in citric buffer and stained 
with 5 mcg/ml propidium iodide in PBS for 1 hour at 4°C. 
DNA content was subsequently measured by FACScan (Bec-
ton Dickinson, USA). All cells with sub-G0 DNA content 
were regarded as dead cells. This figure is representative of 3 
separate experiments.
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Proliferation rates of parental and RARα  infected cells Figure 4
Proliferation rates of parental and RARα  infected 
cells. Cells were seeded into 24-well plates (1 × 104 cell per 
well) and the cell number was counted at days 1,3,5,8 after 
seeding. This figure is representative of 3 separate 
experiments.
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Influence of retinoic acid (ATRA, 5 µM) on the proliferation  of parental and RARα  transfected cells Figure 5
Influence of retinoic acid (ATRA, 5 µM) on the prolif-
eration of parental and RARα  transfected cells. Cells 
were seeded into 24-well plates (1 × 104 cell per well), ATRA 
was added at seeding and the cell number was counted at 
days 1, 3, 5 and 8 after seeding. This figure is representative 
of 3 separate experiments.
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Influence of RARα  overexpression on MDR1 gene activity
We studied intrinsic and ATRA induced expression of
MDR1 gene in all cell lines by semi-quantitative RT-PCR
technique. The basal levels of MDR1 mRNA varied in dif-
ferent wild type cells: in H9 and NB4 cells constitutive
MDR1 gene expression was not revealed, in K562 wild
type cells some MDR1 mRNA was found, in KG-1 cells the
quantity of MDR1 mRNA was large (Fig. 6). It is notewor-
thy that the optimal number of PCR cycles were 33 for
MDR1-specific product in all cells while for studies of KG1
and KG1/RAR cells we used 26 PCR cycles. In RARα  trans-
fected H9 cells the constitutive expression of MDR1 gene
slightly increased, while in KG-1/RAR and NB4/RAR cells
the constitutive MDR1 mRNA quantity was not elevated
in comparison with the wild type cells, it seems to be even
slightly decreased in K562/RAR (Fig. 6). Thus the altera-
tions of the basal level of MDR1 expression in RARα  trans-
formed cells seem to vary in different cell lines.
ATRA (5 µM applied for 48 h) increased MDR1  gene
expression in all examined cell lines either in parental or
RARα  transfected cells (Fig. 6). In H9/RAR cells effect of
ATRA on MDR1 expression was significantly greater in
comparison with parental cells. In other ATRA treated
RARα   transformed cell sublines MDR1  expression was
undistinguishable from ATRA treated parental cells (Fig
6).
Intrinsic and retinoic acid induced expression of MDR1 gene  in parental and RARα  transfected cells Figure 6
Intrinsic and retinoic acid induced expression of 
MDR1 gene in parental and RARα  transfected cells. k- 
– water. ATRA (5 µM) was added to cell cultures 24 h after 
seeding for 48 h. Then the cells were collected and proc-
essed as specified in "Methods" (RNA isolation and reverse 
transcriptase polymerase chain reaction (RT-PCR) analysis of 
MDR1 gene expression). The optimal numbers of PCR cycles 
were 33 for MDR1-specific product for all cells lines except 
KG1 and KG1/RAR, for these cells the numbers of PCR 
cycles for MDR1-specific product were 26. This figure is rep-
resentative of 2 separate experiments.
Evaluation of Rh123 efflux from the parental and cells RARα   transfected cells Figure 7
Evaluation of Rh123 efflux from the parental and 
cells RARα  transfected cells. Cells were loaded with 5 µg/
ml Rh123 for 10 min at 37°C, than washed twice with cold 
PBS, and incubated for 30 min in dye-free medium at 37°C. 
After the completion of incubation, cell were washed twice 
with cold PBS. Cell fluorescence was measured on a flow 
cytometer FACScan (Becton Dikinson, USA). Each measure-
ment counted 5000 events. Non-viable cells were gated out 
of the analysis on the basis of side scatter. This figure is rep-
resentative of 2 separate experiments.Cancer Cell International 2005, 5:15 http://www.cancerci.com/content/5/1/15
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Influence of RARα  gene transformation on Rh123efflux by 
the cells
The retention of Rh123 by the cells is considered as a test
for Pgp functional activity [16,17]. Rh123 efflux from the
cells was increased in K562/RAR cells in comparison with
the parental cell population (Fig. 7B, Table 2). In H9 and
KG-1 RARα  transformed cells there were alterations in the
Rh123 retention (Fig. 7A and 7C): in the populations of
H9/RAR and KG-1/RAR cultures the fraction of more dull
cells decreased in comparison with parental cultures
(mean fluorescence intensity of the cell sublines studied
are given in the table 2). This shows that Pgp activity was
not elevated in these RARα  transformed cell populations
and suggests that there is some decrease in Pgp functional
activity.
There was increase in the portion of Rh123 dull cells after
ATRA treatment both in K562 and K562/RAR cell popula-
tions (mean fluorescence intensity of both populations
decreased approximately on 17%) (Fig. 8C, D, Table 2).
ATRA induced Rh123 efflux from H9/RAR cells, while in
H9 parental population this drug had no effect (Fig. 8A, B,
Table 2). In KG-1/RAR cells ATRA induced very prominent
increase in the number of Rh123 dull cells (more than
70% decrease of mean fluorescence intensity), while in
the parental cell population ATRA decreased mean fluo-
rescence intensity to a lesser extent (Fig. 8E, F, Table 2).
Discussion
The treatment of leukemia with retinoids is aimed on the
induction of leukemic cells differentiation. The question
is: are there interconnections between RA/RARα  regulated
differentiation of leukemic cells and MDR1/Pgp activity?
In this study we have isolated more differentiated variants
of the cultured leukemic cells by the introduction into the
cells of RARα   gene encoding one of RA receptors. All
RARα  transformed leukemic cell populations were charac-
terized by the higher RARα  gene expression in compari-
son with the parental cells. All RARα   transformed
leukemic cell populations became more differentiated.
This was demonstrated by the studies of the
differentiation markers, by the increase in the number of
cells dying by spontaneous apoptosis and by the decrease
of the proliferation rates of most RARα  transfected cell
sublines. Thus, RARα  overexpression could result in the
increase of the differentiation of various leukemic cell
populations.
We compared MDR1 gene expression and Pgp functional
activity tested by Rh123 retention in parental and RARα
transformed cells. The results are summarized in the Table
2. Increased constitutive (uninduced) expression of
MDR1 gene was found in one of four cell lines after RARα
transformation (H9/RAR, Table 2, Fig. 6). In the previous
experiments with melanoma and hepatoblastoma human
cells we have shown that constitutive expression of MDR1
gene was increased after RARα  transfection in both RARα
transformed cell sublines [4]. Thus interconnections
between regulation of the basal MDR1 and RARα  activi-
ties could exist both in the cells of solid tumors and in the
leukemic cells. Our data suggest, that in the cell popula-
tions of solid tumors RARα   overexpression could be
accompanied by constitutive MDR1 over-expression more
often than in the cells of hematopoietic malignancies.
Our study did not reveal the occurrence of the functional
Pgp in leukemic cells studied after RARα  transformation.
In H9/RAR cells elevation of the constitutive MDR1
expression did not lead to the increase in Rh123 efflux
(Fig. 7A, Table 2). Some studies also have described dis-
crepancies between Pgp (protein) or MDR1 mRNA expres-
sion and Pgp function in leukemic cells [18,19]. These
discrepancies could occur for a variety of reasons. Anyway,
our data show that increase in the differentiation of
leukemic cell populations induced by RARα  overexpres-
sion did not result in the elevation of constitutive Pgp
Table 2: Influence of RARα  transformation on the intrinsic and induced expression of MDR1 gene
MDR1 expression Rh123 efflux (mean fluorescence intensity)
Cells intrinsic ATRA induced intrinsic ATRA induced
H9 -+ 450 457
H9/RAR ++ + 506 416
K562 + ++ 446 370
K562/RAR + ++ 403 333
KG-1 ++ +++ 65,7 38,3
KG-1/RAR ++ +++ 90,7 20,2
NB4 - ++ n.d. n.d.
NB4/RAR - ++ n.d. n.d.Cancer Cell International 2005, 5:15 http://www.cancerci.com/content/5/1/15
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functional activity. In our previous study we found that
RARα  overexpression did not change Pgp functional activ-
ity in two RARα   transformed sublines of human cells
(melanoma and hepatoblastoma) but did change it in the
rat cells [4]. It seems that exogeneous RARα  in the cells of
human malignancies does not influence basal Pgp func-
tional activity.
In KG-1/RAR characterized by the increased differentiaion
(Table 1) we had not found increase in the constitutive
MDR1 expression and Pgp functional activity decreased
(Fig. 7C, Table 2). It is known that blood stem cells and
early progenitors expressing CD34 antigen also express
high levels of functionally active Pgp [20]. Maturation of
these cells is accompanied by the decrease in Pgp expres-
sion and even more rapid decrease in Pgp functional activ-
Influence of retinoic acid (ATRA) on Rh123 efflux from the parental and cells RARα  transfected cells Figure 8
Influence of retinoic acid (ATRA) on Rh123 efflux from the parental and cells RARα  transfected cells. ATRA (5 
µM) was added to cell cultures 24 h after seeding for 48 h. Than cells were loaded with 5 µg/ml Rh123 for 10 min at 37°C, than 
washed twice with cold PBS, and incubated for 30 min in dye-free medium at 37°C. After the completion of incubation, cell 
were washed twice with cold PBS. Cell fluorescence was measured on a flow cytometer FACScan (Becton Dikinson, USA). 
Each measurement counted 5000 events. Non-viable cells were gated out of the analysis on the basis of side scatter. This figure 
is representative of 2 separate experiments.Publish with BioMed Central    and   every 
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ity [21]. It may be suggested that alterations of Pgp
function in KG-1/RAR are connected with the differentia-
tion of these cells.
The situation with Pgp functional activity induced by
ATRA in the cells studied differs from the situation with
constitutive activity of this protein. In all three RARα
transfected cells ATRA had induced Pgp fuctional activity
(Fig. 8. Table 2). Moreover, in two RARα  transformed sub-
lines (H9/RAR and KG-1/RAR) ATRA activated Pgp, while
in the parental cells it had either no effect (H9) or acti-
vated Pgp to a lesser extent (KG-1) (Table 2). These data
suggest that RARα  participate in the control of induced,
but not in constitutive Pgp functional activity in leukemic
cells.
The regulation of MDR1 gene transcription and Pgp func-
tional activities are the complex processes [1,2]. The stud-
ies of these processes are underway. Our data show that
RARα  gene overexpression could influence the induced
Pgp functional activity in leukemic cells, i.e. could
participate in the occurrence of multidrug resistance in the
populations of these malignant cells. It seems that this
influence could depend on the cell context.
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